SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients

Clinical trial NCT06042764 · UNKNOWN

Trial details

NCT number: NCT06042764
Sponsor: Sinovac Life Sciences Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Infection of Upper Respiratory Tract Caused by 2019-nCoV

Start date: 2023-08-31
Primary completion: 2024-03-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.